Xeris Biopharma Holdings, Inc. financial data

Symbol
XERS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1375 West Fulton Street, Suite 1300, Chicago, Illinois
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 199 % -8.19%
Quick Ratio 48.6 % +33.5%
Debt-to-equity -4.3K % -637%
Return On Equity 759 %
Return On Assets -18.1 % +17.9%
Operating Margin -20.5 % +56.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149M shares +7.92%
Common Stock, Shares, Outstanding 149M shares +7.92%
Entity Public Float 362M USD +72.8%
Common Stock, Value, Issued 15K USD +7.14%
Weighted Average Number of Shares Outstanding, Basic 148M shares +8.02%
Weighted Average Number of Shares Outstanding, Diluted 148M shares +8.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 22.1M USD +169%
Revenue from Contract with Customer, Excluding Assessed Tax 181M USD +35.3%
Research and Development Expense 25M USD +14%
Operating Income (Loss) -37.2M USD +41.2%
Income Tax Expense (Benefit) 482K USD
Net Income (Loss) Attributable to Parent -59.6M USD +16.6%
Earnings Per Share, Basic -0.43 USD/shares +17.3%
Earnings Per Share, Diluted -0.43 USD/shares +17.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57.6M USD +24.8%
Accounts Receivable, after Allowance for Credit Loss, Current 42.4M USD +40.4%
Inventory, Net 43M USD +17.6%
Assets, Current 170M USD +9.37%
Property, Plant and Equipment, Net 5.83M USD -11%
Operating Lease, Right-of-Use Asset 22.9M USD -3.25%
Intangible Assets, Net (Excluding Goodwill) 104M USD -9.41%
Goodwill 22.9M USD 0%
Other Assets, Noncurrent 5.49M USD +14.3%
Assets 332M USD +0.9%
Accounts Payable, Current 5.8M USD -50.1%
Employee-related Liabilities, Current 12.8M USD +16.9%
Accrued Liabilities, Current 23.5M USD +21%
Liabilities, Current 75.5M USD -5.26%
Deferred Income Tax Liabilities, Net 3.32M USD +16.9%
Operating Lease, Liability, Noncurrent 34M USD -2.45%
Other Liabilities, Noncurrent 7.71M USD +191%
Liabilities 351M USD +11.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -31K USD +60.3%
Retained Earnings (Accumulated Deficit) -651M USD -10.1%
Stockholders' Equity Attributable to Parent -19.3M USD -241%
Liabilities and Equity 332M USD +0.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.3M USD +22.3%
Net Cash Provided by (Used in) Financing Activities 35.2M USD
Net Cash Provided by (Used in) Investing Activities -19.7M USD +55.3%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 149M shares +7.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.76M USD +93.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 61.8M USD +22.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.5M USD -84.7%
Deferred Tax Assets, Valuation Allowance 173M USD +8.94%
Deferred Tax Assets, Gross 18.2M USD +15723%
Operating Lease, Liability 39.3M USD +6.84%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -59.5M USD +16.7%
Lessee, Operating Lease, Liability, to be Paid 73M USD -2.58%
Property, Plant and Equipment, Gross 12.5M USD -2.81%
Operating Lease, Liability, Current 5.31M USD +174%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.23M USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.08M USD +74%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) 307K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33.7M USD -11.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.39M USD +2.52%
Deferred Tax Assets, Operating Loss Carryforwards 119M USD +6.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 694K USD -3.88%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.55M USD +2.5%
Operating Lease, Payments 1.93M USD -4.21%
Additional Paid in Capital 632M USD +4.39%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.89M USD +170%
Amortization of Intangible Assets 10.8M USD 0%
Depreciation, Depletion and Amortization 326K USD -10.4%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.44M USD
Share-based Payment Arrangement, Expense 13.2M USD +18.1%
Operating Leases, Future Minimum Payments, Due in Three Years 6.08M USD +199%
Operating Leases, Future Minimum Payments Due 77.4M USD +255%
Interest Expense 27.4M USD +63.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%